25 February 2020 - - US-based genomics solutions provider Integrated DNA Technologies has launched the xGen Prism DNA Library Prep Kit, designed to produce high-quality Next Generation Sequencing data from precious but challenging samples, assisting in the early detection of cancer mutations and other applications, the company said.

The xGen Prism DNA Library Prep Kit uses a proprietary strategy that maximises sample conversion at industry-leading rates.

The kit is designed to convert DNA from cell-free DNA and formalin-fixed paraffin-embedded tissues into high-quality NGS libraries.

This high performance is important for sensitive applications that depend on the detection of single nucleotide variants in low-quality samples, including oncology samples that are especially difficult to evaluate.

IDT's approach in the new kit virtually eliminates adapter dimers, a common cause of reduced sequencing throughput.

Reducing dimers means more usable data from each sequencing run. The xGen Prism DNA Library Prep Kit is also highly accurate, allowing the detection of ultra-low frequency variants.

This is made possible through the inclusion of unique molecular identifier sequences, which provide enhanced error correction and remove false positives.

The new kit will be featured at the upcoming Advances in Genome Biology and Technology conference in Marco Island, Florida, as part of presentations by IDT staff scientists, and by The McDonnell Genome Institute at Washington University, which will preview early access data of the kit.

IDT is an operating company within Danaher Corp.'s (NYSE: DHR) Life Sciences platform.

Integrated DNA Technologies, Inc. develops, manufactures, and markets nucleic acid products for the life sciences industry in the areas of academic and commercial research, agriculture, medical diagnostics, and pharmaceutical development.

IDT has developed proprietary technologies for genomics applications such as next generation sequencing, CRISPR genome editing, synthetic biology, digital PCR, and RNA interference.

Through its GMP services, IDT manufactures products used by scientists in researching many forms of cancer and most inherited and infectious diseases.

IDT is in custom nucleic acid manufacture, serving over 130,000 life sciences researchers. IDT has its manufacturing headquarters in Coralville, Iowa, USA, with additional manufacturing sites in San Diego, California, USA; Leuven, Belgium; and Singapore.